Actively Recruiting
Evaluation of Next-Generation Software Features for the Rhythmia Mapping System in Catheter-Based Mapping of Cardiac Arrhythmias
Led by Boston Scientific Corporation · Updated on 2026-10-23
100
Participants Needed
8
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating new software features designed for the Rhythmia Mapping System, a device used in catheter-based endocardial mapping for patients with atrial or ventricular tachyarrhythmias. The purpose is to study how these next-generation software updates perform during standard cardiac mapping and ablation procedures. This observational study collects data to help guide the development of improved software for future commercial releases. Participants undergo their usual catheter-based mapping and ablation treatments using the commercial Rhythmia Mapping System. During these standard procedures, raw cardiac signals are streamed from the commercial system to an investigational workstation running prototype software. These new software features are tested in parallel and do not affect the physicians clinical decisions or treatment. During the study, data are collected from the mapping procedures, and physician feedback on the softwares performance is gathered immediately after each procedure. The study involves no changes to the participants usual care. Researchers measure how well the new software performs without impacting patient safety or treatment outcomes. Participation time aligns with the standard care visit, and no additional follow-up related to the software testing is required.
CONDITIONS
Brief Title
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Research Team
S
Susan Hampson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here